ADMA
Adma Biologics, Inc.Company with tickers: ADMA
CIK
1368514
CUSIP
000899104
Shares Outstanding
231,772,715
13F Activity (30d)
308 filings
305 filers
Price
$8.21
Market Cap
$1.87B
P/E Ratio
13.68
EPS (Diluted)
$0.60
52W High
$22.37
52W Low
$7.21
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $114,493,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Cost of Revenue | $33,743,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Gross Profit | $80,750,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Expenses | $22,476,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Research & Development | $2,597,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Income | $58,274,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Net Income | $45,328,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $0.19 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $0.19 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |